Drug Delivery Routes Development Services
Drug delivery route development helps formulation, CMC, and R&D teams determine how a drug should enter the body, reach the target tissue, and maintain an appropriate release profile. Integral BioSystems supports route-specific formulation development for complex molecules, including ophthalmic and injectable products, where solubility, stability, tissue exposure, dosing frequency, and tolerability can affect development feasibility.
Our team develops formulations that control the rate, timing, and location of drug release across multiple delivery routes, helping biotech and pharmaceutical sponsors reduce formulation risk, generate decision-ready data, and prepare candidates for preclinical, clinical, or tech transfer milestones.
20+ Years in Ophthalmic Drug Delivery Development
A significant challenge to the ocular drug delivery scientists is the necessity to circumvent the protective barriers of the eye without tissue damage. The goal of ophthalmic drug delivery is the design of therapeutic systems that will achieve optimal concentrations of the selected drug at the target tissue, for an appropriate duration…
Strategic Development Across Drug Delivery Routes
Selecting the appropriate drug delivery route is a critical formulation decision that can affect bioavailability, tissue exposure, dosing frequency, patient tolerability, and downstream development requirements.
Integral BioSystems helps pharmaceutical and biotech sponsors evaluate route-specific formulation strategies for complex molecules, including small molecules, peptides, proteins, ophthalmic products, injectables, and specialized dosage forms.
Our development approach considers:
- Drug solubility and physicochemical properties
- Stability under route-specific conditions
- Target tissue or systemic exposure requirements
- Desired onset and duration of action
- Dose volume, concentration, and tolerability
- Preclinical, clinical, and tech transfer requirements
This helps sponsors identify practical formulation pathways before significant time and resources are committed to later-stage development.
Routes of Administration in Early-Stage Drug Development
In early-stage drug development, the route of administration should be evaluated in parallel with formulation feasibility, therapeutic objective, and development risk.
Common drug administration routes include oral, injectable, ophthalmic, inhalation, intranasal, dermal, otic, rectal, sublingual, and other specialized delivery approaches. Each route presents different formulation challenges related to absorption, permeability, retention, release rate, and patient use.
Integral BioSystems supports early formulation work that helps sponsors determine whether a proposed route is technically feasible and aligned with the intended therapeutic application.
Injectable, Oral, Inhalation, and Specialized Drug Administration Routes
Integral BioSystems develops formulations across multiple routes of administration, with particular strength in ophthalmic and injectable drug delivery.
Our route-specific formulation experience includes:
-
Injectable drug delivery:
Formulation support for parenteral products where stability, concentration, viscosity, excipient compatibility, and release profile are key considerations. -
Oral drug delivery:
Formulation strategies for compounds affected by solubility, permeability, degradation, or bioavailability limitations. -
Inhalation drug delivery:
Development considerations for localized or systemic delivery through the respiratory tract. -
Ophthalmic drug delivery:
Formulation approaches designed to support ocular residence time, tissue targeting, tolerability, and sustained exposure. -
Intranasal, dermal, otic, rectal, and sublingual delivery:
Specialized route development for programs requiring alternative administration strategies.
By evaluating the delivery route alongside formulation constraints, Integral BioSystems helps sponsors reduce technical uncertainty and generate data that supports development decisions.
Discuss Your Drug Delivery Route Strategy
Choosing the right administration route early can help reduce formulation risk, improve development planning, and support a more efficient path toward preclinical, clinical, or tech transfer milestones.
Integral BioSystems works with biotech and pharmaceutical teams to evaluate route-specific drug delivery challenges and develop practical formulation strategies for complex products.
Contact Integral BioSystems to discuss your molecule, delivery route requirements, and formulation development goals.
What our
clients say
Drug Delivery Route FAQs
What Are the Different Routes of Drug Administration?
Drug administration routes include oral, intravenous, intramuscular, subcutaneous, transdermal, inhalation, nasal, rectal, vaginal, ophthalmic, otic, sublingual, and topical routes.
Why Is the Route of Administration Important in Pharmacology?
The route of administration affects how a drug is absorbed, distributed, metabolized, and eliminated. It can influence bioavailability, onset of action, tissue exposure, dosing frequency, efficacy, and safety.
What Factors Influence the Choice of Drug Delivery Route?
The choice of drug delivery route depends on the drug’s physicochemical properties, therapeutic target, desired onset of action, duration of exposure, dose requirements, patient use considerations, and development stage.
Contact us
To contact us about a project, please include a brief summary of your specific needs with your email. Our company representative will call you back within the next business day.